v3.22.0.1
OPERATING SEGMENTS - Reconciliation (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2020
USD ($)
Sep. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2021
USD ($)
item
Dec. 31, 2020
USD ($)
item
Dec. 31, 2019
USD ($)
item
Reconciliation of net income to EBITDA            
Net loss       $ (1,269.8) $ (4,589.4) $ (149.1)
Income tax provision (benefit)       (10.2) 59.9 (22.5)
Interest expense       458.1 356.9 340.8
Depreciation and amortization       425.0 498.3 450.0
Impairment of long-lived assets, definite and indefinite-lived intangible assets and goodwill       77.2 2,513.9 84.3
Certain operating expense (income)       0.2 (9.4) 14.8
Equity in (earnings) loss of non-consolidated entities       (11.0) 30.9 (30.6)
Impairment of equity method investments recorded in equity in earnings (loss) of non-consolidated entities         8.6  
Cash distributions from non-consolidated entities       12.5 17.4 35.8
Attributable EBITDA       3.7 0.2 5.0
Investment expense (income)       (9.2) 10.1 (16.0)
Other expense (income)       0.1 (66.9) (13.3)
Other non-cash rent expense (benefit)       (24.9) (4.9) 25.7
General and administrative - unallocated:            
Merger, acquisition and other costs       13.7 24.6 15.5
Stock-based compensation expense       43.1 25.4 4.4
Adjusted EBITDA       (291.7) (999.2) 771.4
Impairment of goodwill $ 405.3 $ 156.8 $ 1,744.3   2,306.4  
Impairment of long-lived assets       77.2 177.9 84.3
Impairment of indefinite-lived intangible assets       0.0 15.2 0.0
Impairment of definite-lived intangible assets         14.4  
Derivative liability fair value adjustment       0.0 (89.4) 23.5
(Gain) loss on extinguishment of debt       14.1 (93.6) 16.6
Gain on derivative liability           5.8
Attributable EBITDA            
Reconciliation of net income to EBITDA            
Income tax provision (benefit)       0.3 0.1 0.4
Interest expense       0.2 0.1  
Depreciation and amortization       5.6 3.2 3.4
Equity in (earnings) loss of non-consolidated entities       (11.0) 30.9 (30.6)
Equity in (earnings) loss of non-consolidated entities excluding International theatre joint ventures       (13.5) 27.4 (29.2)
Equity in earnings (loss) of International theatre joint ventures       (2.5) (3.5) 1.4
Attributable EBITDA       3.7 0.2 5.0
Investment expense (income)       (0.1) (0.4) (0.7)
Other expense (income)       0.2 0.7 0.5
Other expense (income)            
General and administrative - unallocated:            
Derivative liability fair value adjustment         (89.4) 23.5
(Gain) loss on extinguishment of debt       14.4   16.6
Financing fees       1.0 39.3  
Foreign currency transaction (gains) losses       (9.8) (2.8) 1.5
Credit losses (income) related to contingent lease guarantees       (5.7) 15.0  
Other expense (income) | Convertible Notes due 2026            
General and administrative - unallocated:            
(Gain) loss on extinguishment of debt         (93.6)  
Other expense (income) | Embedded Derivative Financial Instruments [Member]            
General and administrative - unallocated:            
Derivative liability fair value adjustment         109.0  
DCIP            
Reconciliation of net income to EBITDA            
Equity in (earnings) loss of non-consolidated entities       12.2 (14.5) 25.4
Cash distributions from non-consolidated entities       12.2    
Oden trade name            
General and administrative - unallocated:            
Impairment of indefinite-lived intangible assets         12.5  
Nordic trade names            
General and administrative - unallocated:            
Impairment of indefinite-lived intangible assets         2.7  
Domestic theatres            
General and administrative - unallocated:            
Impairment of goodwill         1,276.1  
Impairment of definite-lived intangible assets         14.4  
International theatres            
General and administrative - unallocated:            
Impairment of goodwill         1,030.3  
International theatres | Nordic trade names            
General and administrative - unallocated:            
Impairment of indefinite-lived intangible assets         2.7  
U. S. markets            
General and administrative - unallocated:            
Impairment of long-lived assets       $ 61.3 $ 152.5 $ 84.3
Tangible asset impairment, number of theatres | item       77 101 40
Tangible asset impairment, number of screens | item       805 1,139 512
International markets.            
General and administrative - unallocated:            
Impairment of long-lived assets       $ 15.9 $ 25.4  
Tangible asset impairment, number of theatres | item       14 37 14
Tangible asset impairment, number of screens | item       118 340 148
International markets. | International theatres | Oden trade name            
General and administrative - unallocated:            
Impairment of indefinite-lived intangible assets         $ 12.5